Atomic layer deposition for core-shell microparticle vaccines enabling programmable antigen delivery and enhanced humoral immune responses
This study demonstrates that atomic layer deposition (ALD) can be used to coat core-shell microparticle vaccines with a programmable nanoscopic alumina shell, enabling sustained antigen release that significantly enhances germinal center expansion, antibody affinity, and long-lived plasma cell generation compared to traditional bolus vaccination.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Vaccines work by teaching the immune system to recognize a specific invader, usually a virus or bacterium, so that the body can fight it off quickly if it ever returns. For many common diseases, a shot or two is enough to train the body's defenses. However, for some difficult pathogens like HIV, the immune system needs a much longer and more complex training session. The body must find extremely rare immune cells and then repeatedly encourage them to change and improve their ability to recognize the virus, a process that can take months or even years of repeated exposure. Traditional vaccines often deliver their message all at once and then disappear, which is not always enough to trigger this deep, long-term learning. Scientists have long sought a way to deliver a vaccine slowly over time, mimicking a series of booster shots in a single injection, but creating a material that releases medicine steadily without damaging the delicate biological components inside has proven difficult.
In a new study, researchers have developed a method to create tiny, solid spheres that can hold a vaccine and release it on a precise schedule. They started with a liquid vaccine containing a specific HIV protein and turned it into a dry powder using a process similar to spray-drying, which traps the protein inside a glass-like shell. On top of these tiny particles, they used a technique called atomic layer deposition to coat them with an incredibly thin layer of aluminum oxide, essentially building a microscopic barrier around the vaccine. This barrier acts like a timer; it prevents the vaccine from escaping until the shell naturally dissolves in the body. By changing how many layers of this coating they apply, the scientists could control exactly when the vaccine would start to release and how long it would continue to do so.
The researchers tested these coated particles in mice to see if the delicate HIV protein survived the harsh manufacturing process. They found that the protein remained intact and functional, retaining its complex shape even after being dried out and coated. When they injected these particles under the skin of mice, the vaccine did not rush out all at once. Instead, the aluminum shell held it back for a period that depended on the thickness of the coating. Once the shell began to dissolve, the vaccine was released slowly and steadily over several weeks. This slow release meant that the vaccine stayed at the injection site for a long time, allowing the body's immune cells to find and absorb it gradually, rather than being overwhelmed by a sudden flood that disappears quickly.
This steady presence of the vaccine had a profound effect on the immune response. In mice that received the standard, fast-releasing vaccine, the immune cells that help coordinate the defense were active for a short time and then faded away. In contrast, the mice with the slowly releasing particles showed a continuous expansion of these immune cells for over two months. The immune system had more time to refine its attack, leading to the production of antibodies that bound much more tightly to the virus and stayed attached for longer periods. Furthermore, the study showed that this single injection created a large number of long-lived immune cells in the bone marrow, which are responsible for maintaining protection for years.
The researchers also observed how the vaccine moved through the body. They found that the particles did not just dissolve into a liquid; instead, they were taken up by immune cells or dissolved in the tissue, releasing the vaccine right where it was needed. This slow, local delivery allowed the vaccine to accumulate on specialized cells in the lymph nodes that are crucial for training the immune system. The study suggests that by controlling the timing of vaccine release, scientists can guide the immune system through the complex steps needed to fight difficult diseases, potentially turning a single shot into a powerful, long-lasting defense without the need for multiple clinic visits.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.